發明
中華民國
108100196
I 695891
早發型帕金森病(D331Y)PLA2G6突變基因嵌入模式與藥物篩選平台和方法
長庚醫療財團法人
2020/06/11
本發明關於早發型帕金森病之基因檢測模式和篩選用於治療早發型帕金森病的藥物之平台和方法。 Disclosed is a (D331Y) PLA2G6 knockin mouse, which shows similar clinical symptoms to those of patients suffering from Parkinson's disease (PD), and begins to display early-onset cell death of dopaminergic neurons in its substantia nigra (SN), synucleinopathy, and tau pathology at the age of about 6 months, wherein the dopaminergic neurons exhibit mitochondrial structural abnormality and dysfunction. Treatment of the (D331Y) PLA2G6 knockin mice with L-Dopa shows a good response. The (D331Y) PLA2G6 knockin mouse can be used as a platform for developing a mrdicament and method for treating PD.
版權所有 © 國家科學及技術委員會 National Science and Technology Council All Rights Reserved.
建議使用IE 11或以上版本瀏覽器,最佳瀏覽解析度為1024x768以上|政府網站資料開放宣告
主辦單位:國家科學及技術委員會 執行單位:台灣經濟研究院 網站維護:台灣經濟研究院